Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Department of Error
The Lancet ( IF 98.4 ) Pub Date : 2024-12-19 , DOI: 10.1016/s0140-6736(24)02752-1
The Lancet ( IF 98.4 ) Pub Date : 2024-12-19 , DOI: 10.1016/s0140-6736(24)02752-1
Jairath V, Acosta Felquer ML, Jaihyun Cho R. IL-23 inhibition for chronic inflammatory disease. Lancet 2024; 404: 1679–92—In this Therapeutics paper, the name IL-23A in the abstract should have been IL-23. Also, the model of TYK2 activation shown in the figure is incorrect. TYK2 activates via IL-12Rβ1, not IL-23R. These corrections were made to the online version as of December 19, 2024.
更新日期：2024-12-20
京公网安备 11010802027423号